Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 7, 2012, Pages

  Muroya, Yoshikazu ^a   Ito, Osamu ^a   Rong, Rong ^a   Takashima, Kenta ^a   Ito, Daisuke ^a   Cao, Pengyu ^a   Nakamura, Yasuhiro ^a   Joh, Kensuke ^b   Kohzuki, Masahiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sendai Syakaihoken Hospital   (Japan)

Author keywords

Albuminuria; Fatty acid metabolism; Lipid accumulation; Lipotoxicity; Proximal tubular epithelial cells; Puromycin aminonucleoside

Indexed keywords

CYTOCHROME P450 4A; ESTROGEN RECEPTOR ALPHA; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1ALPHA; PUROMYCIN AMINONUCLEOSIDE; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FATTY ACID METABOLISM DISORDER; HYPOALBUMINEMIA; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; LIPID STORAGE; LIPOTOXICITY; MALE; METABOLIC DISORDER; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SPRAGUE DAWLEY RAT;

EID: 84867125733     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00365.2011     Document Type: Article

References (46)

1. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor (PPAR). J Biol Chem 273: 5678-5684, 1998.
2. Asanuma K, Campbell KN, Kim K, Faul C, Mundel P. Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. Proc Natl Acad Sci USA 104: 10134-10139, 2007.
3. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340, 1997.
4. Cho KH, Kim HJ, Kamanna VS, Vaziri ND. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim Biophys Acta 1800: 6-15, 2010.
5. Duner F, Lindstrom K, Hultenby K, Hulkko J, Patrakka J, Tryggvason K, Haraldsson B, Wernerson A, Pettersson E. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis. Nephron Exp Nephrol 116: e42-e52, 2010.
6. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
7. Hamilton JA, Era S, Bhamidipati SP, Reed RG. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci USA 88: 2051-2054, 1991.
8. Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1 (PGC-1) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and-γ. Identification of novel leucine-rich interaction motif within PGC-1. J Biol Chem 277: 40265-40274, 2002.
9. Ishizuka T, Ito O, Tan L, Ogawa S, Kohzuki M, Omata K, Takeuchi K, Ito S. Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney. Hypertens Res 26: 929-936, 2003.
10. Ito O, Alonso-Galicia M, Hopp KA, Roman RJ. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol Renal Physiol 274: F395-F404, 1998.
11. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, Hirata Y, Goto A, Fujita T, Omata M. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 62: 1628-1637, 2002.
12. Kamijo Y, Hora K, Kono K, Takahashi K, Higuchi M, Ehara T, Kiyosawa K, Shigematsu H, Gonzalez FJ, Aoyama T. PPARα protects proximal tubular cells from acute fatty acid toxicity. J Am Soc Nephrol 18: 3089-3100, 2007.
13. Kamijo Y, Hora K, Tanaka N, Usuda N, Kiyosawa K, Nakajima T, Gonzalez FJ, Aoyama T. Identification of functions of peroxisome proliferator-activated receptor α in proximal tubules. J Am Soc Nephrol 13: 1691-1702, 2002.
14. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 57: 1949-1961, 2000.
15. Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296: F1297-F1306, 2009.
16. Kim HJ, Vaziri ND. Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney. Am J Nephrol 29: 607-614, 2009.
17. Kim MS, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Suppression of estrogen-related receptor α and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response. J Lipid Res 46: 2282-2288, 2005.
18. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 91: 10878-10882, 1994.
19. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106: 847-856, 2000.
20. Li S, Nagothu KK, Desai V, Lee T, Branham W, Moland C, Megyesi JK, Crew MD, Portilla D. Transgenic expression of proximal tubule peroxisome proliferator-activated receptorin mice confers protection during acute kidney injury. Kidney Int 76: 1049-1062, 2009.
21. Li S, Wu P, Yarlagadda P, Vadjunec NM, Proia AD, Harris RA, Portilla D. PPARα ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity. Am J Physiol Renal Physiol 286: F572-F580, 2004.
22. Lin H, Cheng CF, Hou HH, Lian WS, Chao YC, Ciou YY, Djoko B, Tsai MT, Cheng CJ, Yang RB. Disruption of guanylyl cyclase-G protects against acute renal injury. J Am Soc Nephrol 19: 339-348, 2008.
23. Miyata N, Roman RJ. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41: 175-193, 2005.
24. Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, Sakakida M, Kishikawa H, Araki E. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26: 1507-1512, 2003.
25. Ouali F, Djouadi F, Merlet-Benichou C, Bastin J. Dietary lipids regulate β-oxidation enzyme gene expression in the developing rat kidney. Am J Physiol Renal Physiol 275: F777-F784, 1998.
26. Portilla D, Dai G, McClure T, Bates L, Kurten R, Megyesi J, Price P, Li S. Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney Int 62: 1208-1218, 2002.
27. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, Proia AD. Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278: F667-F675, 2000.
28. Praga M, Morales E. Renal damage associated with proteinuria. Kidney Int Suppl: S42-S46, 2002.
29. Regner KR, Zuk A, Van Why SK, Shames BD, Ryan RP, Falck JR, Manthati VL, McMullen ME, Ledbetter SR, Roman RJ. Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. Kidney Int 75: 511-517, 2009.
30. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998.
31. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
32. Saku K, Sata T, Naito S, Fukushima K, Takebayashi S, Arakawa K. Apolipoproteins in human biopsied nephrotic kidneys. Int Urol Nephrol 20: 429-438, 1988.
33. Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576: 1-14, 2002.
34. Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERR). J Biol Chem 278: 9013-9018, 2003.
35. Shibouta Y, Terashita Z, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats. Kidney Int 39: 920-929, 1991.
36. Sladek R, Bader JA, Giguere V. The orphan nuclear receptor estrogenrelated receptor alpha is a transcriptional regulator of the human mediumchain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 17: 5400-5409, 1997.
37. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J Biol Chem 278: 26597-26603, 2003.
38. Tanaka T, Miyata T, Inagi R, Fujita T, Nangaku M. Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol 165: 1979-1992, 2004.
39. Thomas ME, Harris KP, Walls J, Furness PN, Brunskill NJ. Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol 283: F640-F647, 2002.
40. Tolwani RJ, Hamm DA, Tian L, Sharer JD, Vockley J, Rinaldo P, Matern D, Schoeb TR, Wood PA. Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice. PLoS Genet 1: e23, 2005.
41. Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, Parikh SM. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest 121: 4003-4014, 2011.
42. Valle I, Alvarez-Barrientos A, Arza E, Lamas S, Monsalve M. PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 66: 562-573, 2005.
43. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20: 1868-1876, 2000.
44. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with agedependent cardiac toxicity. J Biol Chem 275: 22293-22299, 2000.
45. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18: 543-551, 2003.
46. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.